ClinicalTrials.gov
public full text
Public Domain
Resveratrol for Pain Due to Endometriosis
This study aims to verify whether the use of 40 mg of resveratrol per day associated with monophasic contraceptive pill (levonorgestrel 0.15mg/ethinyl estradiol 0.03mg) reduces pelvic pain at the end of 2 months of treatment, compared to the use of the pill with placebo.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Relugolix for Endometriosis Associated Pain#1140530
- Resveratrol Trial for Relief of Pain in Pseudoachondroplasia#849102
- Can resveratrol treatment control the progression of induced periodontal disease? a systematic review and meta-analysis of preclinical studies#1017122
- SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain#800424
- Effects of Simvastatin and Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients#863613
Record · ID 889576
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive